Ticker brief
TEVA TEVA PHARMACEUTICAL IND LTD
Consumer, Non-cyclical · Pharmaceuticals
last close
$39.41
1 day
-2.0%
14 days
-4.1%
mkt cap
$40.3B
signals 14d
19
authors 14d
17
crowd 14d
-0.1σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 42% mid · 62 pctile own 1y | IV/HV 1.25× |
| Skew — 25Δ RR 30d | -0.003 81 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +0.86 thin | 5-session Δ -0.20 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2026-03-17 (z=3.0) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-04 → 2026-10-16 · now +0.30 (−1 bearish … +1 bullish)
Who spoke17
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Brad_E_Schulz | C | · | 2 | +0.28 |
| @SteveDJacobs | C | -2.95 | 2 | -0.02 |
| @PrimeTrading_ | C | -2.18 | 1 | +0.20 |
| @MartyChargin | C | -0.56 | 1 | +0.50 |
| @theflynews | C | · | 1 | +0.50 |
| @newsinvesting | C | · | 1 | +0.50 |
| @CNBC | C | +0.31 | 1 | +0.50 |
| @alphacharts | B | -1.27 | 1 | +0.00 |
| @zohmbastic | C | -2.94 | 1 | +0.30 |
| @OptionsHawk | B | -1.11 | 1 | +0.45 |
| @BiopharmIQ | B | · | 1 | +0.50 |
| @joinautopilot | C | -0.83 | 1 | +0.50 |
| @investseekers | B | +0.02 | 1 | +0.20 |
| @bullishchart | C | -1.21 | 1 | +0.50 |
| @TalkMarkets | C | · | 1 | +0.50 |
| @Capitol_Forum | A | -0.51 | 1 | +0.00 |
| @BiotechCH | B | +1.42 | 1 | +0.30 |
Recent signals19of 19 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-16 | @BiotechCH | +0.30 | Highlights encouraging cross-indication data and upcoming catalysts for three biotech firms. | -5.0% | tweet ↗ |
| 2026-10-14 | @Capitol_Forum | +0.00 | Healthcare roundup reports generic-drug competition claims and Alignment Health's CMS lawsuit. | -3.2% | tweet ↗ |
| 2026-10-12 | @TalkMarkets | +0.50 | Discusses the positive implications of Weltruza's approval for Teva. | -4.3% | tweet ↗ |
| 2026-10-11 | @bullishchart | +0.50 | Reports approval of Teva's WELTRUZA and a bullish moving-average crossover. | -4.1% | tweet ↗ |
| 2026-10-11 | @SteveDJacobs | +0.15 | TEVA qualifies under a Minervini trend scan, though the author favors more actionable high-ATR candidates. | -4.1% | tweet ↗ |
| 2026-10-11 | @SteveDJacobs | -0.20 | Rejects TEVA as a candidate because its 2.88% ATR is below the author's 3.23% threshold. | -4.1% | tweet ↗ |
| 2026-10-10 | @investseekers | +0.20 | European Patent Office revoked a semaglutide patent, potentially enabling earlier generic entry. | -4.1% | tweet ↗ |
| 2026-10-09 | @Brad_E_Schulz | +0.25 | Lists watched stocks gaining at least 4% on at least 1.5 times average volume. | -4.1% | tweet ↗ |
| 2026-10-09 | @joinautopilot | +0.50 | Daily news roundup reports discrete corporate, index and regulatory events across six directly affected stocks. | -4.1% | tweet ↗ |
| 2026-10-09 | @BiopharmIQ | +0.50 | Biotech news-and-mover list covering regulatory, enrollment, and data events; ticker list capped at six. | -4.1% | tweet ↗ |
| 2026-10-09 | @Brad_E_Schulz | +0.30 | Lists intraday gainers trading at least 1.5 times average volume. | -4.1% | tweet ↗ |
| 2026-10-09 | @OptionsHawk | +0.45 | TEVA reached another new high and is described as a top performer this year. | -4.1% | tweet ↗ |
| 2026-10-09 | @zohmbastic | +0.30 | Reports that TEVA hit the monthly $42 level. | -4.1% | tweet ↗ |
| 2026-10-09 | @alphacharts | +0.00 | Provides a daily ticker watch list without levels, entry intent or direction. | -4.1% | tweet ↗ |
| 2026-10-09 | @CNBC | +0.50 | Teva wins FDA approval for monthly schizophrenia treatment Weltruza. | -4.1% | tweet ↗ |
| 2026-10-09 | @newsinvesting | +0.50 | FDA approved Teva's once-monthly injectable schizophrenia treatment WELTRUZA. | -4.1% | tweet ↗ |
| 2026-10-09 | @theflynews | +0.50 | Teva announces FDA approval for Weltruza. | -4.1% | tweet ↗ |
| 2026-10-09 | @MartyChargin | +0.50 | FDA approved Teva's once-monthly WELTRUZA injection for adult schizophrenia. | -4.1% | tweet ↗ |
| 2026-10-04 | @PrimeTrading_ | +0.20 | Ranks liquid leaders showing ten-week moving-average pullback structures; capped at six. | -0.3% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.